TABLE 2.
Randomization | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Screening | Intervention | Maintenance | ||||||||
Months | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10–15 |
Intervention group | S | S | S | V | X | X | X | X | X | M |
MEMS use | ||||||||||
Attention control group | S | S | S | V | Y | Y | Y | Y | Y | M |
MEMS use |
Note: MEMS, Medication Event Monitoring System; S, MEMS use only; at the completion of Month 3, those who were medication adherent exited the study and those with medication nonadherence were randomized; V, In-person visit to begin either SystemCHANGE™ intervention or attention control (patient education) intervention. SystemCHANGE™ teaches patients to use person-level quality improvement strategies to link adherence to established daily routines, environmental cues and supportive people. Attention control (patient education) included discussion of first of 6 transplant health-related brochures; X, Telephone call to receive feedback (MEMS report) and discuss implemented medication adherence solution; Y, telephone call to review transplant-related education materials; M, MEMS use only; at the completion of Month 15, the MEMS were returned and the study was concluded.